Review



on-targetplus nontargeting control pool  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher on-targetplus nontargeting control pool
    On Targetplus Nontargeting Control Pool, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/on+targetplus+nontargeting+pool/pm39794329-165-15-19
    Average 90 stars, based on 1 article reviews
    on-targetplus nontargeting control pool - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Control:

    Article Title: Surfactant inhibits ATP-induced release of interleukin-1β via nicotinic acetylcholine receptors
    Article Snippet: As previously described ( 19 , 23 ), the expression of nAChR subunits α7, α9, and α10 ( CHRNA 7, CHRNA 9, CHRNA 10) was reduced in U937 cells using siRNA SMARTpool (Thermo Fisher Scientific, Schwerte, Germany). .. ON-TARGETplus nontargeting pool (Thermo Fisher Scientific) was used as a control for nonspecific effects. ..



    Similar Products

    90
    Thermo Fisher on-targetplus nontargeting control pool
    On Targetplus Nontargeting Control Pool, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/on+targetplus+nontargeting+pool/pm39794329-165-15-19
    Average 90 stars, based on 1 article reviews
    on-targetplus nontargeting control pool - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher dharmacon on-targetplus nontargeting control pool
    Dharmacon On Targetplus Nontargeting Control Pool, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/on+targetplus+nontargeting+pool/10__1186_slash_s12935___023___02956___0-36-7-11
    Average 90 stars, based on 1 article reviews
    dharmacon on-targetplus nontargeting control pool - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    86
    Thermo Fisher targetplus nontargeting pool sirna duplexes
    Targetplus Nontargeting Pool Sirna Duplexes, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/on+targetplus+nontargeting+pool/pm36625475-90-25-16
    Average 86 stars, based on 1 article reviews
    targetplus nontargeting pool sirna duplexes - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    90
    Thermo Fisher on-targetplus nontargeting pool containing four different nontargeting sirna oligonucleotides
    On Targetplus Nontargeting Pool Containing Four Different Nontargeting Sirna Oligonucleotides, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/on+targetplus+nontargeting+pool/pmc03891534-48-7-10
    Average 90 stars, based on 1 article reviews
    on-targetplus nontargeting pool containing four different nontargeting sirna oligonucleotides - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher control sirna on targetplus nontargeting pool
    A. Western blot <t>for</t> <t>STAG2</t> in HB-CLS-1, TCC-SUP and SV-HUC cells after treatment with 50 nM scrambled control or STAG2 <t>siRNA</t> for 48, 72, or 96 hours. Figure representative of three independent experiments. B. Copy number variation (CNV) array indicating percentage CNV gained (red) or lost (blue) in each chromosome of HB-CLS-1, SV-HUC, or TCC-SUP cells treated with scrambled control or STAG2 siRNA for 96 hours. C. Percentage of diploid or aneuploid HB-CLS-1, TCC-SUP, or T24 cells after transfection with scrambled control, shSTAG2-1, or shSTAG2-2. Data from flow cytometry are represented as mean + SEM. D. Percentage of HB-CLS-1, TCC-SUP, T24, BO2, or UM-UC-3 cells in G1/G0, S, or G2 phase of the cell cycle in scrambled control, shSTAG2-1, or shSTAG2-2 (HB-CLS-1, TCC-SUP, T24, BO2), or pCDH or FLAG-STAG2 (UM-UC-3). Individual comparisons made using unpaired Student’s t test. Data from flow cytometry are represented as mean + SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
    Control Sirna On Targetplus Nontargeting Pool, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/on+targetplus+nontargeting+pool/on+targetplus+smartpool+sirna/pmc09583756-215-14-20
    Average 90 stars, based on 1 article reviews
    control sirna on targetplus nontargeting pool - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    A. Western blot for STAG2 in HB-CLS-1, TCC-SUP and SV-HUC cells after treatment with 50 nM scrambled control or STAG2 siRNA for 48, 72, or 96 hours. Figure representative of three independent experiments. B. Copy number variation (CNV) array indicating percentage CNV gained (red) or lost (blue) in each chromosome of HB-CLS-1, SV-HUC, or TCC-SUP cells treated with scrambled control or STAG2 siRNA for 96 hours. C. Percentage of diploid or aneuploid HB-CLS-1, TCC-SUP, or T24 cells after transfection with scrambled control, shSTAG2-1, or shSTAG2-2. Data from flow cytometry are represented as mean + SEM. D. Percentage of HB-CLS-1, TCC-SUP, T24, BO2, or UM-UC-3 cells in G1/G0, S, or G2 phase of the cell cycle in scrambled control, shSTAG2-1, or shSTAG2-2 (HB-CLS-1, TCC-SUP, T24, BO2), or pCDH or FLAG-STAG2 (UM-UC-3). Individual comparisons made using unpaired Student’s t test. Data from flow cytometry are represented as mean + SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

    Journal: Cancer research communications

    Article Title: STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer

    doi: 10.1158/2767-9764.crc-22-0155

    Figure Lengend Snippet: A. Western blot for STAG2 in HB-CLS-1, TCC-SUP and SV-HUC cells after treatment with 50 nM scrambled control or STAG2 siRNA for 48, 72, or 96 hours. Figure representative of three independent experiments. B. Copy number variation (CNV) array indicating percentage CNV gained (red) or lost (blue) in each chromosome of HB-CLS-1, SV-HUC, or TCC-SUP cells treated with scrambled control or STAG2 siRNA for 96 hours. C. Percentage of diploid or aneuploid HB-CLS-1, TCC-SUP, or T24 cells after transfection with scrambled control, shSTAG2-1, or shSTAG2-2. Data from flow cytometry are represented as mean + SEM. D. Percentage of HB-CLS-1, TCC-SUP, T24, BO2, or UM-UC-3 cells in G1/G0, S, or G2 phase of the cell cycle in scrambled control, shSTAG2-1, or shSTAG2-2 (HB-CLS-1, TCC-SUP, T24, BO2), or pCDH or FLAG-STAG2 (UM-UC-3). Individual comparisons made using unpaired Student’s t test. Data from flow cytometry are represented as mean + SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

    Article Snippet: Cells were transfected with 50nM of STAG2 siRNA (SMARTpool siGENOME siRNA, Thermo Scientific) or control siRNA (On TargetPlus nonTargeting pool, Thermo Scientific) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).

    Techniques: Western Blot, Control, Transfection, Flow Cytometry

    A. Western blot demonstrating STAG2 protein expression in T24 cells transfected with scrambled control or STAG2 siRNA for 24, 48, and 72 hours. GAPDH used as loading control. Figure is representative of three independent experiments. B. T24 cells transfected with scrambled control or STAG2 siRNA, were seeded on top of a Transwell insert and allowed to travel through Matrigel-coated membrane (top panels, invasion) or uncoated membrane (bottom panels, migration) for 24 hours. C. Average number of T24 control or siSTAG2 cells per field view that migrated through uncoated membrane (left panel) or invaded through Matrigel-coated membrane (right panel) after 24 hours. D. T24 cells treated with scrambled control, shSTAG2-1, or shSTAG2-2, seeded in the top of a Transwell insert and allowed to move through Matrigel-coated membrane (top, invasion) or uncoated membrane (bottom, migration) for 24 hours. E. Average number of T24 control, shSTAG2-1, or shSTAG2-2 cells per field view that migrated through uncoated membrane (left panel) or invaded through Matrigel-coated membrane (right panel) after 24 hours. A minimum of 16 random fields were counted for each condition. F. Western blot for STAG2 protein expression in UM-UC-3 cells transduced with pEGFP (control vector) or pEGFP-STAG2 (STAG2 overexpression vector). GAPDH used as a loading control. Figure is representative of three independent experiments. G. UM-UC-3 empty vector (EV) or pEGFP-STAG2 (STAG2-overexpressed) cells seeded in the top of a Transwell insert and allowed to move through Matrigel-coated membrane (top panels, invasion) or uncoated membrane (bottom panels, migration) for 24 hours. H. Average number of UM-UC-3 EV or pEGFP-STAG2 cells per field view that migrated through uncoated membrane (left panel) or invaded through Matrigel-coated membrane (right panel) after 24 hours. I. UM-UC-3 control (pCDH) or FLAG-STAG2 cells seeded in the top of a Transwell insert and allowed to move through Matrigel-coated membrane (top panels, invasion) or uncoated membrane (bottom panels, migration) for 24 hours. J. Average number of UM-UC-3 control or FLAG-STAG2 cells per field view that migrated through uncoated membrane (left panel) or invaded through Matrigel-coated membrane (right panel) after 24 hours. A minimum of 12 random fields were counted for each experiment. Data represented as mean + SEM. Individual comparisons made using unpaired Student’s t test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

    Journal: Cancer research communications

    Article Title: STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer

    doi: 10.1158/2767-9764.crc-22-0155

    Figure Lengend Snippet: A. Western blot demonstrating STAG2 protein expression in T24 cells transfected with scrambled control or STAG2 siRNA for 24, 48, and 72 hours. GAPDH used as loading control. Figure is representative of three independent experiments. B. T24 cells transfected with scrambled control or STAG2 siRNA, were seeded on top of a Transwell insert and allowed to travel through Matrigel-coated membrane (top panels, invasion) or uncoated membrane (bottom panels, migration) for 24 hours. C. Average number of T24 control or siSTAG2 cells per field view that migrated through uncoated membrane (left panel) or invaded through Matrigel-coated membrane (right panel) after 24 hours. D. T24 cells treated with scrambled control, shSTAG2-1, or shSTAG2-2, seeded in the top of a Transwell insert and allowed to move through Matrigel-coated membrane (top, invasion) or uncoated membrane (bottom, migration) for 24 hours. E. Average number of T24 control, shSTAG2-1, or shSTAG2-2 cells per field view that migrated through uncoated membrane (left panel) or invaded through Matrigel-coated membrane (right panel) after 24 hours. A minimum of 16 random fields were counted for each condition. F. Western blot for STAG2 protein expression in UM-UC-3 cells transduced with pEGFP (control vector) or pEGFP-STAG2 (STAG2 overexpression vector). GAPDH used as a loading control. Figure is representative of three independent experiments. G. UM-UC-3 empty vector (EV) or pEGFP-STAG2 (STAG2-overexpressed) cells seeded in the top of a Transwell insert and allowed to move through Matrigel-coated membrane (top panels, invasion) or uncoated membrane (bottom panels, migration) for 24 hours. H. Average number of UM-UC-3 EV or pEGFP-STAG2 cells per field view that migrated through uncoated membrane (left panel) or invaded through Matrigel-coated membrane (right panel) after 24 hours. I. UM-UC-3 control (pCDH) or FLAG-STAG2 cells seeded in the top of a Transwell insert and allowed to move through Matrigel-coated membrane (top panels, invasion) or uncoated membrane (bottom panels, migration) for 24 hours. J. Average number of UM-UC-3 control or FLAG-STAG2 cells per field view that migrated through uncoated membrane (left panel) or invaded through Matrigel-coated membrane (right panel) after 24 hours. A minimum of 12 random fields were counted for each experiment. Data represented as mean + SEM. Individual comparisons made using unpaired Student’s t test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

    Article Snippet: Cells were transfected with 50nM of STAG2 siRNA (SMARTpool siGENOME siRNA, Thermo Scientific) or control siRNA (On TargetPlus nonTargeting pool, Thermo Scientific) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).

    Techniques: Western Blot, Expressing, Transfection, Control, Membrane, Migration, Transduction, Plasmid Preparation, Over Expression